Pfizer and PhRMA, a pharmaceutical trade association, funded a medical index that pushes LGBTQ ideologies on young patients while penalizing American hospitals that refuse to follow the index’s criteria, according to The Washington Free Beacon.
The Human Rights Campaign (HRC) introduced the Healthcare Equality Index (HEI) in 2022, a scorecard that surveys U.S. hospitals “dedicated to the equitable treatment and inclusion of their LGBTQ+ patients, visitors, and employees” according to The Washington Free Beacon. PhRMA and Pfizer fund the index that rates hospitals based on their compliance with its criteria.
According to the HEI, hospitals that want to attain a perfect score must exhibit LGBTQ symbols, use patients’ preferred pronouns and administer LGBTQ training programs approved by the HRC, according to the scoring criteria.
The HRC criteria pressures doctors to provide treatments to patients who claim to be transgender without showing symptoms of gender dysphoria while punishing medical institutions that oppose this medical procedure. The index also deducts 25 points from medical facilities for conduct deemed discriminatory against the LGBTQ community and for refusing to perform a hysterectomy or mastectomy on young patients.
Beth Rempe, a former nurse at the Children’s National Hospital in Washington, D.C., said that doctors at her previous employer were required to wear pins displaying the transgender flag, made to ask kids unaffected by gender dysphoria for their preferred pronouns and instructed staff members to perform sex change surgeries on patients based on their “mood,” according to the Free Beacon.
“I was concerned that I would eventually have to administer puberty blockers and hormones, not just use the pronouns,” Rempe said, according to the Free Beacon. “I kept finding myself in situations I wasn’t comfortable with ethically.”
Two hospitals in Texas, UT Southwestern Medical Center and Children’s Health in Dallas, got penalized last year for halting puberty blockers on patients affected by gender dysphoria while continuing to use them to treat precocious puberty, according to the Free Beacon.
“The actions taken by UT Southwestern Medical Center and Children’s Health are life-threatening for transgender youth and required decisive action on our part,” said Tari Hanneman, director of Health & Aging at the HRC, in a press release.
A spokesperson for PhRMA, Brian Newell said, “Our work with the [Human Rights Campaign] has primarily focused on issues impacting patient access and affordability, including for those with HIV,” according to the Free Beacon.
The Human Rights Campaign, PhRMA and Pfizer did not immediately respond to the Daily Caller News Foundation’s request for comment.
All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].
DONATE TO BIZPAC REVIEW
Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!
Comment
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.
